Payment overview · 2025
General Payments
$130.39
2 reported records · 2 companies
Healthcare provider profile · identity verified
Stephen Michael Grossman, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine|Geriatric Medicine · FRESNO, CA · NPI 1942220926
Verified facts
What the public records show
CMS Open Payments records show Stephen Michael Grossman, M.D. received $130.39 in general payments during 2025 across 2 reported records.
Teva Pharmaceuticals USA, Inc. accounted for 85.5% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
Teva Pharmaceuticals USA, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported AUSTEDO as an associated drug or biological on 28 records involving 15 distinct recipient NPIs. Public Medicare Part D data also shows 22 claims for Austedo by this doctor in 2024.
Teva Pharmaceuticals USA, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported AUSTEDO XR as an associated drug or biological on 86263 records involving 23643 distinct recipient NPIs. Public Medicare Part D data also shows 17 claims for Austedo Xr by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | Unresolved — no canonical attribution shown | $111.49 | 85.5% | 1 | 2025 |
| Vanda Pharmaceuticals Inc. | Unresolved — no canonical attribution shown | $18.90 | 14.5% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Education | $111.49 | 1 |
| Food and Beverage | $18.90 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| FANAPT Normalized: fanapt |
Drug | Vanda Pharmaceuticals Inc. | $18.90 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. Exact reporting entity; no affiliate inference |
2025 | AUSTEDO open payments reported associated product |
CMS Open Payments — General Payments 28 supporting records · 15 recipient NPIs · example record 1247249192 |
Austedo · 2024 Exact normalized brand match · 1 Part D row |
22 | suppressed by CMS |
| Teva Pharmaceuticals USA, Inc. Exact reporting entity; no affiliate inference |
2025 | AUSTEDO XR open payments reported associated product |
CMS Open Payments — General Payments 86263 supporting records · 23643 recipient NPIs · example record 1247244228 |
Austedo Xr · 2024 Exact normalized brand match · 1 Part D row |
17 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 1090 | 219 |
| Levothyroxine Sodium | Levothyroxine Sodium | 1040 | 100 |
| Atorvastatin Calcium | Atorvastatin Calcium | 999 | 125 |
| Furosemide | Furosemide | 602 | 75 |
| Gabapentin | Gabapentin | 511 | 73 |
| Famotidine | Famotidine | 502 | 74 |
| Metformin Hcl | Metformin Hcl | 441 | 53 |
| Amlodipine Besylate | Amlodipine Besylate | 435 | 73 |
| Quetiapine Fumarate | Quetiapine Fumarate | 406 | 65 |
| Eliquis | Apixaban | 387 | 51 |
| Tamsulosin Hcl | Tamsulosin Hcl | 324 | 48 |
| Lisinopril | Lisinopril | 295 | 50 |
| Tramadol Hcl | Tramadol Hcl | 266 | 84 |
| Pantoprazole Sodium | Pantoprazole Sodium | 264 | 46 |
| Baclofen | Baclofen | 258 | 36 |
| Lorazepam | Lorazepam | 258 | 87 |
| Metoprolol Tartrate | Metoprolol Tartrate | 241 | 44 |
| Mirtazapine | Mirtazapine | 233 | 24 |
| Oxycodone Hcl | Oxycodone Hcl | 211 | 51 |
| Levetiracetam | Levetiracetam | 204 | 23 |
| Clonazepam | Clonazepam | 192 | 32 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 190 | 30 |
| Sertraline Hcl | Sertraline Hcl | 187 | 27 |
| Potassium Chloride | Potassium Chloride | 185 | 45 |
| Risperidone | Risperidone | 175 | 11 |
| Jardiance | Empagliflozin | 168 | 14 |
| Morphine Sulfate | Morphine Sulfate | 163 | 36 |
| Pregabalin | Pregabalin | 159 | 37 |
| Myrbetriq | Mirabegron | 156 | suppressed |
| Metoprolol Succinate | Metoprolol Succinate | 146 | 38 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 134 | 17 |
| Lacosamide | Lacosamide | 129 | 16 |
| Finasteride | Finasteride | 124 | 12 |
| Losartan Potassium | Losartan Potassium | 123 | 29 |
| Divalproex Sodium | Divalproex Sodium | 120 | 17 |
| Latanoprost | Latanoprost | 120 | 24 |
| Alprazolam | Alprazolam | 119 | 23 |
| Donepezil Hcl | Donepezil Hcl | 118 | 25 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 110 | 44 |
| Hydrochlorothiazide | Hydrochlorothiazide | 109 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 108 | 15 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 106 | 21 |
| Olanzapine | Olanzapine | 104 | 19 |
| Prednisone | Prednisone | 103 | 20 |
| Glipizide | Glipizide | 100 | 15 |
| Paroxetine Hcl | Paroxetine Hcl | 100 | 11 |
| Januvia | Sitagliptin Phosphate | 99 | suppressed |
| Trazodone Hcl | Trazodone Hcl | 98 | 22 |
| Carvedilol | Carvedilol | 93 | 20 |
| Ezetimibe | Ezetimibe | 92 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 87 | 20 |
| Duloxetine Hcl | Duloxetine Hcl | 86 | 18 |
| Lactulose | Lactulose | 85 | 16 |
| Sucralfate | Sucralfate | 80 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 76 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 76 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 75 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 74 | 16 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 72 | suppressed |
| Memantine Hcl | Memantine Hcl | 72 | 17 |
| Omeprazole | Omeprazole | 69 | 20 |
| Allopurinol | Allopurinol | 68 | 11 |
| Topiramate | Topiramate | 68 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 67 | 16 |
| Gemtesa | Vibegron | 65 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 65 | 31 |
| Spironolactone | Spironolactone | 65 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 64 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 63 | 14 |
| Valsartan | Valsartan | 61 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 60 | 19 |
| Ramipril | Ramipril | 59 | suppressed |
| Aripiprazole | Aripiprazole | 58 | 12 |
| Pravastatin Sodium | Pravastatin Sodium | 58 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 55 | suppressed |
| Simvastatin | Simvastatin | 55 | 11 |
| Colchicine | Colchicine | 54 | suppressed |
| Gemfibrozil | Gemfibrozil | 54 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 54 | 13 |
| Digoxin | Digoxin | 53 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 53 | 23 |
| Alendronate Sodium | Alendronate Sodium | 52 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 51 | suppressed |
| Entresto | Sacubitril/Valsartan | 51 | suppressed |
| Xarelto | Rivaroxaban | 51 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 50 | 26 |
| Hydralazine Hcl | Hydralazine Hcl | 50 | 12 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 50 | 24 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 49 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 47 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 45 | 37 |
| Citalopram Hbr | Citalopram Hydrobromide | 44 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 40 | suppressed |
| Levofloxacin | Levofloxacin | 40 | 31 |
| Glimepiride | Glimepiride | 39 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 38 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 37 | suppressed |
| Cephalexin | Cephalexin | 36 | 26 |
| Nystatin | Nystatin | 36 | 21 |
| Zolpidem Tartrate | Zolpidem Tartrate | 36 | suppressed |
| Belsomra | Suvorexant | 35 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 35 | suppressed |
| Lamotrigine | Lamotrigine | 35 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 35 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 34 | suppressed |
| Methadone Hcl | Methadone Hcl | 33 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 32 | suppressed |
| Tradjenta | Linagliptin | 32 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 31 | suppressed |
| Novolin R Flexpen | Insulin Regular, Human | 31 | suppressed |
| Lorazepam Intensol | Lorazepam | 30 | 18 |
| Nystop | Nystatin | 30 | 19 |
| Buspirone Hcl | Buspirone Hcl | 29 | suppressed |
| Fentanyl | Fentanyl | 29 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 29 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 29 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 29 | 22 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 28 | 18 |
| Enulose | Lactulose | 28 | suppressed |
| Ibuprofen | Ibuprofen | 28 | 11 |
| Rybelsus | Semaglutide | 28 | suppressed |
| Humalog | Insulin Lispro | 27 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 25 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 25 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 24 | 11 |
| Ingrezza | Valbenazine Tosylate | 24 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 24 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 24 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 23 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 23 | suppressed |
| Rytary | Carbidopa/Levodopa | 23 | suppressed |
| Atenolol | Atenolol | 22 | suppressed |
| Austedo | Deutetrabenazine | 22 | suppressed |
| Rexulti | Brexpiprazole | 22 | suppressed |
| Timolol Maleate | Timolol Maleate | 22 | suppressed |
| Phenytoin | Phenytoin | 21 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 21 | suppressed |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 20 | 19 |
| Meloxicam | Meloxicam | 20 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 20 | suppressed |
| Methotrexate | Methotrexate Sodium | 20 | suppressed |
| Namzaric | Memantine Hcl/Donepezil Hcl | 20 | suppressed |
| Nyamyc | Nystatin | 20 | suppressed |
| Phenobarbital | Phenobarbital | 20 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 20 | suppressed |
| Budesonide | Budesonide | 19 | suppressed |
| Folic Acid | Folic Acid | 19 | suppressed |
| Nifedipine Er | Nifedipine | 19 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 19 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 19 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 18 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 18 | suppressed |
| Temazepam | Temazepam | 18 | suppressed |
| Austedo Xr | Deutetrabenazine | 17 | suppressed |
| Haloperidol | Haloperidol | 17 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 16 | 12 |
| Farxiga | Dapagliflozin Propanediol | 16 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 16 | suppressed |
| Oxycontin | Oxycodone Hcl | 16 | suppressed |
| Ozempic | Semaglutide | 16 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 16 | suppressed |
| Acetylcysteine | Acetylcysteine | 15 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 15 | suppressed |
| Lovastatin | Lovastatin | 15 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 15 | 14 |
| Torsemide | Torsemide | 15 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 15 | suppressed |
| Acyclovir | Acyclovir | 14 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 14 | suppressed |
| Calcitonin-Salmon | Calcitonin,salmon,synthetic | 14 | suppressed |
| Humulin R | Insulin Regular, Human | 14 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 14 | suppressed |
| Ranolazine Er | Ranolazine | 14 | suppressed |
| Azithromycin | Azithromycin | 13 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 13 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 13 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 13 | suppressed |
| Rivastigmine | Rivastigmine | 13 | suppressed |
| Tobramycin | Tobramycin | 13 | 11 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 13 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 12 | suppressed |
| Bumetanide | Bumetanide | 12 | suppressed |
| Dulera | Mometasone/Formoterol | 12 | suppressed |
| Klor-Con 10 | Potassium Chloride | 12 | suppressed |
| Nitroglycerin | Nitroglycerin | 12 | suppressed |
| Primidone | Primidone | 12 | suppressed |
| Procrit | Epoetin Alfa | 12 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 12 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 12 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 11 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 11 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 11 | 11 |
| Descovy | Emtricitabine/Tenofov Alafenam | 11 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 11 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 11 | suppressed |
| Tivicay | Dolutegravir Sodium | 11 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 11 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $130.39 · 2 records | Teva Pharmaceuticals USA, Inc. | FANAPT | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with Teva Pharmaceuticals USA, Inc.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error